GI & Endoscopy

Tokyo's Astellas Pharma and Cambridge, Mass.-based Ironwood Pharmaceuticals announced positive top-line results from their combined phase III trial for chronic constipation drug linaclotide.

Here are the five most read gastroenterology/endoscopy stories for Jan. 23 to Jan. 27, 2017.

The National Institute for Health and Care Excellence is evaluating Amsterdam-Zuidoost, Netherlands-based Norgine's Endocuff Vision.

Throughout the United States, healthcare facilities hospitalize millions of Americans to treat various digestive diseases.

Xuong Lu, MD, is a gastroenterologist at Pittsburgh Gastroenterology Associates.

Here are two gastroenterologists in the news this past week.

American College of Gastroenterology has released new clinical guidelines in the American Journal of Gastroenterology.

Synergy Pharmaceuticals has received FDA approval for Trulance (plecanatide), a treatment for adult chronic idiopathic constipation.

Reno, Nev.-based Gastroenterology Consultants welcomed James Doyle, MD, according to Northern Nevada Business Weekly.

VMG Health's 2016 Intellimarker Multi-Specialty ASC Study includes statistics on ASC revenue per case.